MAP2K1 and cancer: Mitogen-activated protein kinase 1 (MAPK1), rapidly accelerated fibrosarcoma 1 (Raf1), son of sevenless 1 (SOS1), B-rapidly accelerated fibrosarcoma (B-Raf), epidermal growth factor receptor (EGFR), A-Raf, BCL2 associated agonist of cell death (Bad), myelocytomatosis oncogene (Myc), Jun proto-oncogene (Jun), and myeloid cell leukemia 1 (Mcl1) were mapped to pathways related to apoptosis or cancers (Additional file 9: Table S8).